Two Sigma Securities’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,894
Closed -$222K 1951
2020
Q4
$222K Buy
+2,894
New +$217K 0.01% 1309
2017
Q1
Sell
-3,516
Closed -$50K 1184
2016
Q4
$50K Buy
3,516
+1,886
+116% +$29.2K 0.02% 600
2016
Q3
$29K Buy
1,630
+605
+59% +$10K 0.01% 588
2016
Q2
$18K Buy
+1,025
New +$18.3K 0.01% 383
2015
Q1
Sell
-3,968
Closed -$138K 355
2014
Q4
$138K Buy
+3,968
New +$161K 0.12% 189

Other funds holding ARNA

Two Sigma Securities's ARNA Position: Q1 2021 in Review

Two Sigma Securities sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2021, closing a stake of 2,894 shares — an estimated $222K sold.

Two Sigma Securities first reported a position in ARNA in Q4 2014 and held it in 5 quarters. The position peaked at $222K in Q4 2020. 235 funds tracked by Wall St. Rank hold ARNA as of Q1 2021.

  • Two Sigma Securities reported no remaining Arena Pharmaceuticals Inc position as of Q1 2021 after selling out during the quarter.
  • Two Sigma Securities sold 2,894 Arena Pharmaceuticals Inc shares in Q1 2021, an estimated $222K.
  • Two Sigma Securities first reported a position in Arena Pharmaceuticals Inc in Q4 2014 and held it in 5 quarters.
  • Two Sigma Securities's Arena Pharmaceuticals Inc position peaked at $222K in Q4 2020.
  • 235 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2021.

Based on Two Sigma Securities's 13F filing for Q1 2021, filed 17 May 2021.